United States · FDA National Drug Code directory
Rezurock
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 79802-200_65249371-3fc5-4a85-a999-9ed367b8dd73
- Product NDC
- 79802-200
- Form
- TABLET
- Composition / generic term
- belumosudil
- Labeler
- Kadmon Pharmaceuticals, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210716
- Source listing expiry
- 20271231
Source-listed ingredients
- BELUMOSUDIL — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (79802-200-30) / 30 TABLET in 1 BOTTLE · 79802-200-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →